Long-term outcome of ischemic cardiomyopathy after autologous myoblast cell-sheet implantation

We present the case of a 22-year-old woman with ischemic cardiomyopathy (ICM) who underwent mitral valve replacement and coronary artery bypass graft for infective endocarditis. Ventricular assist device therapy was recommended. After cell sheet therapy, cardiac function and clinical symptoms significantly improved, and the improvement persisted for>36 months without ventricular assist device therapy or heart transplantation.This regenerative treatment might be feasible and effective for severe heart failure of ischemic etiology.
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research